Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In The News: Changes At EnVivo, CSL, Biomed, Orexo, NCPA, And More

Executive Summary

Deborah Dunsire takes top leadership post at EnVivo and Paul Perreault at CSL Limited; Robert DeLuca to lead U.S. rollout of Orexo’s Zubsolv; Former CMS Deputy Director joins Avalere; more personnel announcements in this month’s column.

You may also be interested in...



Shareholder Revolt at AMAG Squelches All-Stock Merger with Equally Struggling Allos

AMAG shareholders have killed plans for what they considered an ill-conceived merger and one shareholder calls the vote a "clear signal" that current management isn't fit to run the company.

Critical Path Institute Seeks "Respected, Well Networked" CEO As Woosley Plans Retirement

Board member Bob Assenzo will lead a search committee to find a replacement for CPI's founding force, Raymond Woosley, who will step down next January.

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS055526

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel